Pre-market hot trades in US stocks: Inovio Pharma pre-market down 7.34%; Rocky Mountain Chocolate pre-market up 3.25%
I'm LongbridgeAI, I can summarize articles.Inovio Pharma pre-market fell 7.34%; Rocky Mountain Chocolate pre-market rose 3.25%; ARTIUS II ACQUISITION INC COM USD0.0001 CL A (SUB/RIGHTS) 27/11/29 pre-market rose 354.17%; INVO Fertility pre-market rose 173.75%; IP Strategy pre-market rose 153.17%
Pre-market Hot Trades in US Stocks
Inovio Pharma is down 7.34% in pre-market trading. Based on recent key news:
-
On August 14, Inovio Pharma reported a second-quarter loss that was lower than Wall Street expectations, with the stock price rising 18%. The company reported a loss of $0.07 per share, exceeding expectations by $0.15. Its main candidate drug INO-3107 has made progress in FDA review, with a PDUFA date expected on October 30. The company's cash position is strong, expected to support operations until the end of the first quarter of 2027. Source: Benzinga
-
On August 14, Inovio Pharma's partner ApolloBio reported positive Phase III results for VGX-3100 in China, further boosting market confidence. Source: Benzinga The biotech industry has been active recently, with significant capital inflows.
Rocky Mountain Chocolate is up 3.25% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Top Gainers in Pre-market US Stocks
ARTIUS II ACQUISITION INC COM USD0.0001 CL A (SUB/RIGHTS) 27/11/29 is up 354.17% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
INVO Fertility is up 173.75% in pre-market trading. Based on recent key news:
-
On August 17, MDxHealth SA (NASDAQ:MDXH) is down 14.7% to $0.69 in pre-market trading, after rising 75% on Friday. MDxHealth's second-quarter sales performance exceeded expectations last week and confirmed its fiscal year 2026 sales guidance above expectations.
-
On August 17, Creative Global Technology Holdings Ltd (NASDAQ:CGTL) is down 14.3% to $3.78 in pre-market trading, after rising 20% on Friday.
-
On August 17, Gauzy Ltd (NASDAQ:GAUZ) is down 11.2% to $0.37 in pre-market trading, after falling over 12% on Friday. Market volatility is significant, and macroeconomic data needs attention.
IP Strategy is up 153.17% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation